Progressive Resistance Training Improves Bradykinesia, Motor Symptoms and Functional Performance in Patients with Parkinson’s Disease

Progressive Resistance Training Improves Bradykinesia, Motor Symptoms and Functional Performance in Patients with Parkinson’s Disease

Ariel Vieira de Moraes Filho, 1 Sandro Nobre Chaves, 2, 3 Wagner Rodrigues Martins, 4 Grassyara Pinho Tolentino, 2 Rita de Cássia Pereira Pinto Homem, 2 Gleyverton Landim de Farias, 2 Bruno Leonardo Fischer, 2 Juliene Azevedo Oliveira, 1 Samantha Kênia Abreu Pereira, 1 Samuel Es...

Full description

Bibliographic Details
Main Authors:	Vieira de Moraes Filho A, Chaves SN, Martins WR, Tolentino GP, de Cássia Pereira Pinto Homem R, Landim de Farias G, Fischer BL, Oliveira JA, Pereira SKA, Vidal SE, Mota MR, Moreno Lima R, Jacó de Oliveira R
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-01-01
Series:	Clinical Interventions in Aging
Subjects:	parkinson disease physical exercise resistance training substantia nigra
Online Access:	https://www.dovepress.com/progressive-resistance-training-improves-bradykinesia-motor-symptoms-a-peer-reviewed-article-CIA

Similar Items

Changes of neurons and blood vessels of human substantia nigra in aging: Morphometric study
by: Krivokuća Zdenka, et al.
Published: (2017-01-01)

Mitochondrial DNA mutations in Parkinson's disease brain
by: David K. Simon, et al.
Published: (2017-04-01)

MODERN STEREOLOGICAL EVALUATION IN THE AGING HUMAN SUBSTANTIA NIGRA
by: Shuang Y Ma, et al.
Published: (2011-05-01)

Revising the Role of the Ventrolateral Periaqueductal Gray in the Fear Circuit:
by: Wright, Kristina M.
Published: (2021)

Subthalamic control of dopamine release in the substantia nigra
by: Barstow, Karen L.
Published: (2019)

Transcranial sonography in Parkinson’s disease
by: I. V. Bayborodina, et al.
Published: (2018-03-01)

Non-linear developmental trajectory of electrical phenotype in rat substantia nigra pars compacta dopaminergic neurons
by: Martial A Dufour, et al.
Published: (2014-10-01)

INTERACTION OF VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) AND NEUROMELANIN PIGMENT AMONG THE MIDBRAIN DOPAMINERGIC NEURONS, IN MAN
by: P. Pasbakhsh, et al.
Published: (2004-05-01)

INTERACTION OF VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) AND NEUROMELANIN PIGMENT AMONG THE MIDBRAIN DOPAMINERGIC NEURONS, IN MAN
by: P. Pasbakhsh, et al.
Published: (2004-02-01)

Effect of potassium channel blocker Tetraethylammonium pretreatment on prevention of the 6-OHDA-induced chronic Parkinson's disease in rats
by: H. Haghdoost-Yazdi, et al.
Published: (2016-06-01)

An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease
by: Patricia Tagliaferro, et al.
Published: (2015-10-01)

The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease
by: E. Ilijic, et al.
Published: (2011-08-01)

Correlates of Substantia Nigra Echogenicity in Healthy Children
by: Schaeff, Sulamith
Published: (2021)

TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion
by: Kevin Rostasy, et al.
Published: (2003-02-01)

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
by: Timothy J. Collier, et al.
Published: (2007-04-01)

Evidence of functional duplicity of Nestin expression in the adult mouse midbrain
by: Parisa Farzanehfar, et al.
Published: (2017-03-01)

The application value of quantitative susceptibility mapping in evaluating substantia nigra "swallow tail sign" in the diagnosis of Parkinson's disease
by: Xiao-jun GUAN, et al.
Published: (2018-04-01)

Hypoxic-ischemic injury decreases anxiety-like behavior in rats when associated with loss of tyrosine-hydroxylase immunoreactive neurons of the substantia nigra
by: Hei Ming-Yan, et al.
Published: (2012-01-01)

Hypoxic-ischemic injury decreases anxiety-like behavior in rats when associated with loss of tyrosine-hydroxylase immunoreactive neurons of the substantia nigra
by: Hei Ming-Yan, et al.
Published: (2012-01-01)

Dietary and Intraperitoneal Administration of Selenium Provide Comparable Protection in the 6-Hydroxydopamine Lesion Rat Model of Parkinson's Disease
by: Cecilia M. Fox, et al.
Published: (2007-01-01)

The Cortico-Basal Ganglia-Cerebellar Network: Past, Present and Future Perspectives
by: Demetrio Milardi, et al.
Published: (2019-10-01)

OXIDATIVE STRESS-DEPENDENT ALTERED IMMUNE RESPONSES AND CELL DEATH IN SUBSTANTIA NIGRA AFTER OZONE EXPOSURE IN RAT
by: Selva eRivas - Arancibia, et al.
Published: (2015-05-01)

Effect of D-amphetamine on dopaminergic neurons of substantia nigra and expression of tyrosine hydroxylase in striatum and pre-frontal cortex of D-amphetamine treated Wistar rats
by: Sarun Koirala, et al.
Published: (2014-10-01)

Histomorphological Effects of Nicotine on Selected Parts of the Brain of Adult Wistar Rats
by: John Chukwuma Oyem, et al.
Published: (2018-07-01)

Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice
by: Heather A. Boger, et al.
Published: (2009-03-01)

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat
by: Alison L. McCormack, et al.
Published: (2002-07-01)

Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood–brain barrier, and damage in the nigral dopaminergic system
by: Mayka Tomás-Camardiel, et al.
Published: (2004-06-01)

Basal ganglia disorders associated with imbalances in the striatal striosome and matrix compartments
by: Jill R. Crittenden, et al.
Published: (2011-09-01)

The Use of Physiological Signals in Brainstem/Midbrain fMRI
by: Andy Schumann, et al.
Published: (2018-10-01)

Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging
by: Dmitrii E. Korzhevskii, et al.
Published: (2021-09-01)

Neuroprotective effect of Lactobacillus plantarum DP189 on MPTP-induced Parkinson's disease model mice
by: Lei Wang, et al.
Published: (2021-10-01)

EL NÚCLEO PEDUNCULOPONTINO Y SU RELACIÓN CON LA FISIOPATOLOGÍA DE LA ENFERMEDAD DE PARKINSON
by: LISETTE BLANCO LEZCANO, et al.
Published: (2012-09-01)

Electrophysiological evidence for functionally distinct neuronal populations in the human substantia nigra
by: Ashwin eRamayya, et al.
Published: (2014-09-01)

A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets
by: Jannik Prasuhn, et al.
Published: (2020-11-01)

Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia
by: Tertia D. Purves-Tyson, et al.
Published: (2020-09-01)

Effect of potassium channel blocker 4-aminopyridine pretreatment on the 6-OHDA-induced Parkinson's disease in rats
by: M. Sofiabadi, et al.
Published: (2015-06-01)

Proximity of Substantia Nigra Microstimulation to Putative GABAergic Neurons Predicts Modulation of Human Reinforcement Learning
by: Ashwin G. Ramayya, et al.
Published: (2017-05-01)

THE ORGANIZATION OF NON-DOPAMINERGIC NIGRAL PROJECTIONS TO THE THALAMIC NUCLEUS OF THE RAT
by: Mehdizadeh M, et al.
Published: (2001-01-01)

Sex Hormones and Prognosis of Neonatal Seizures
by: J Gordon Millichap
Published: (2004-12-01)

Semi-Automatic Signature-Based Segmentation Method for Quantification of Neuromelanin in Substantia Nigra
by: Gašper Zupan, et al.
Published: (2019-11-01)